Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRONTO-Pump: LY900014 vs Insulin Lispro in T1D
NCT03433677Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2018
- Primary completion
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of insulin lispro-aabc in type 1 diabetes mellitus (T1D), sponsored by Eli Lilly and Company. Started Feb 2018; status: completed.
02
Drugs
insulin lispro-aabc
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03433677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03433677.